Drug Approval Process


Making Drug Regulation Smarter Will Save Canadian Lives

Canadian regulations clearly restrict access to new medical innovations by placing a general ban on their use until Health Canada completes duplicate reviews already undertaken (earlier and faster) by regulators in Europe and the U.S. Regulators in these jurisdictions bear responsibility for the health and safety of populations that dwarf Canada's population of less than 35 million. Canada's current approach imposes considerable delays on Canadians struggling with illness. A closer look suggests the delays did much more than cause needless discomfort.